| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | -0.069 | 0.2 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | -0.089 | 0.2 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | 0.038 | 0.2 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.038 | 0.2 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.2 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |